The Institutional Biosafety Committee, or IBC, ensures the safe biohazardous materials in research. The goal: eliminate or reduce the potential exposure of personnel or the environment.
“Biohazardous materials” are defined as materials of biological origin that have the capacity to produce deleterious effects on humans or animals.
- recombinant DNA molecules
- microorganisms classified in various Risk Groups (RG-1, RG-2, RG-3, or RG-4) and their biological products
- specimens known to (or reasonably expected to) contain human pathogens
- hazardous microorganisms
- combinations of or waste derived from these
This responsibility is described in the IBC Policy Procedure Manual 5 5 2015, including IBC's Standard Operating Procedures.
The UMKC IBC is the IBC-of-record for research at affiliated Kansas City institutions, including Children's Mercy Hospital, Saint Luke's Hospital, and Truman Medical Center.
The IBC and its Biosafety Officers (BSOs) are responsible to evaluate and monitor research and teaching at UMKC and the affiliated institutions for biological safety considerations.